AMLX
Price
$12.42
Change
+$0.09 (+0.73%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
1.36B
139 days until earnings call
Intraday BUY SELL Signals
IPSC
Price
$0.46
Change
-$0.10 (-17.86%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
48.66M
119 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMLX vs IPSC

Header iconAMLX vs IPSC Comparison
Open Charts AMLX vs IPSCBanner chart's image
Amylyx Pharmaceuticals
Price$12.42
Change+$0.09 (+0.73%)
Volume$7.63K
Capitalization1.36B
Century Therapeutics
Price$0.46
Change-$0.10 (-17.86%)
Volume$12.06K
Capitalization48.66M
AMLX vs IPSC Comparison Chart in %
AMLX
Daily Signal:
Gain/Loss:
IPSC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AMLX vs. IPSC commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and IPSC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (AMLX: $12.33 vs. IPSC: $0.56)
Brand notoriety: AMLX and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 68% vs. IPSC: 46%
Market capitalization -- AMLX: $1.36B vs. IPSC: $40.13M
AMLX [@Biotechnology] is valued at $1.36B. IPSC’s [@Biotechnology] market capitalization is $40.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 5 TA indicator(s) are bullish while IPSC’s TA Score has 5 bullish TA indicator(s).

  • AMLX’s TA Score: 5 bullish, 5 bearish.
  • IPSC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Biotechnology) experienced а -6.87% price change this week, while IPSC (@Biotechnology) price change was +0.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

AMLX is expected to report earnings on Apr 01, 2026.

IPSC is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($1.36B) has a higher market cap than IPSC($48.7M). AMLX YTD gains are higher at: 226.190 vs. IPSC (-44.228). IPSC has higher annual earnings (EBITDA): -6.16M vs. AMLX (-196.3M). AMLX has more cash in the bank: 181M vs. IPSC (156M). AMLX has less debt than IPSC: AMLX (5.96M) vs IPSC (51.5M). IPSC has higher revenues than AMLX: IPSC (114M) vs AMLX (-249K).
AMLXIPSCAMLX / IPSC
Capitalization1.36B48.7M2,782%
EBITDA-196.3M-6.16M3,188%
Gain YTD226.190-44.228-511%
P/E Ratio2.69N/A-
Revenue-249K114M-0%
Total Cash181M156M116%
Total Debt5.96M51.5M12%
TECHNICAL ANALYSIS
Technical Analysis
AMLXIPSC
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signal:
Gain/Loss:
IPSC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MECAX49.750.28
+0.57%
AMG GW&K International Small Cap N
FCIKX17.860.09
+0.51%
NYLI PineStone International Eq Inv Cl
TSFAX14.470.05
+0.35%
Touchstone Small Cap A
FCCVX39.63N/A
N/A
Fidelity Advisor Convertible Secs C
FIKZX22.93N/A
N/A
Fidelity Advisor Asset Manager 50% Z

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-2.76%
XOMAO - AMLX
68%
Closely correlated
+0.08%
XOMAP - AMLX
51%
Loosely correlated
-0.18%
OCUL - AMLX
49%
Loosely correlated
+2.41%
RGNX - AMLX
45%
Loosely correlated
+0.43%
IPSC - AMLX
44%
Loosely correlated
N/A
More

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with IMNM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
N/A
IMNM - IPSC
54%
Loosely correlated
-0.51%
CRSP - IPSC
52%
Loosely correlated
-5.47%
ARWR - IPSC
49%
Loosely correlated
-0.19%
RXRX - IPSC
49%
Loosely correlated
-1.27%
FATE - IPSC
48%
Loosely correlated
-7.14%
More